Colorectal Cancer Patients With Liver Metastases and Severe Hyperbilirubinemia: A Consecutive Series That Explores the Benefits and Risks of Chemotherapy

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3951
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Study of Hepatic Arterial Infusion Chemotherapy for Colorectal Cancer Patients With Synchronous Liver Metastases

The journal of the Japanese Practical Surgeon Society
1993English

Surgical Treatment of Patients With Colorectal Cancer and Synchronous Liver Metastases

HPB
HepatologyGastroenterology
2016English

A Systematic Review of a Liver‐first Approach in Patients With Colorectal Cancer and Synchronous Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2014English

Management of a Patient With Metastatic Colorectal Cancer and Liver Metastases

Case Reports in Oncological Medicine
Oncology
2014English

Genomic Characterization of Liver Metastases From Colorectal Cancer Patients

Oncotarget
Oncology
2016English

Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients With Colorectal Liver Metastases

Annals of Surgical Oncology
OncologySurgery
2016English

Preoperative Chemotherapy in Colorectal Cancer Patients With Synchronous Liver Metastasis

Molecular and Clinical Oncology
Cancer ResearchOncology
2020English

Intestinal Complications After Chemotherapy for Patients With Unresected Primary Colorectal Cancer and Synchronous Metastases

Gut
Gastroenterology
2003English

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy